Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the investigational study drug everolimus
may be used to increase the effectiveness of chemotherapy treatment for patients with
advanced lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Cancer Research and Biostatistics Clinical Trials Consortium
Collaborators:
Novartis Pharmaceuticals Providence Cancer Center, Earle A. Chiles Research Institute University of Arizona